`RESEARCH
`
`
`
`APPLICATION NUMBER:
`
`212480Orig1s000
`
`OFFICER/EMPLOYEE LIST
`
`
`
`
`
`MEMORANDUM
`
`DATE:
`
`DEPARTMENT OF HEAL TH AND HUMAN SERVICES
`PUBLIC HEALTH SERVICE
`FOOD AND DRUG ADMINISTRATION
`CENTER FOR DRUG EVALUATION AND RESEARCH
`
`TO:
`
`Administrative file for NDA 212480 and sNDA 204671/S-14
`
`FROM:
`
`CAPT Anitra Johnson, Regulatory Health Project Manager
`Division of Antiviral Products, Office of Antimicrobial Products
`
`SUBJECT: Officer/Employee List for NDA 212480 and sNDA 204671/S-14
`
`APPLICATION/DRUG:
`
`NDA 212480 SOVALDI (sofosbuvir), 200 mg tablets and sNDA
`20467 1/S-14 SOVALDI (sofosbuvir), 150 mg and 200 mg oral
`pellets
`
`The following officers or employees of FDA participated in. the decision to approve this
`application and consented to be identified on this list:
`
`Birnkrant, Debra
`Chikhale, Elsbeth
`Choi, Su-Young
`Dorantes, Angelica
`El-Kamary, Samer
`Englund, Erika
`Ghantous, Hanan
`Griffiths, LaShawn
`Harris, Sarah
`Hassan, Hazem
`Johnson, Anitra
`Kolejian, Sevan
`Lewis, David
`Li, Ruojing
`Li, Zheng
`Lunn, George
`Min, Stacey
`Mishra, Lalji
`Murray, Jeffrey
`O'Rear, iulian
`Ou, Mei
`Soldatova, Lyudmila
`Strayhorn, Suzanne
`
`Reference ID: 4489595
`
`
`
`Struble, Kim
`Swank, Kimberly
`Villasurda, Philip
`Walker, Morgan
`Wilson, Valerie
`
`Reference ID: 4489595
`
`